280 related articles for article (PubMed ID: 11522090)
1. Hyperhomocysteinemia, diabetes mellitus, and carotid atherosclerosis independently increase atherosclerotic vascular disease outcome in Japanese patients with end-stage renal disease.
Haraki T; Takegoshi T; Kitoh C; Kajinami K; Wakasugi T; Hirai J; Shimada T; Kawashiri M; Inazu A; Koizumi J; Mabuchi H
Clin Nephrol; 2001 Aug; 56(2):132-9. PubMed ID: 11522090
[TBL] [Abstract][Full Text] [Related]
2. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS).
McQuillan BM; Beilby JP; Nidorf M; Thompson PL; Hung J
Circulation; 1999 May; 99(18):2383-8. PubMed ID: 10318658
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism in methylenetetrahydrofolate reductase gene: its impact on plasma homocysteine levels and carotid atherosclerosis in ESRD patients receiving hemodialysis.
Lim PS; Hung WR; Wei YH
Nephron; 2001 Mar; 87(3):249-56. PubMed ID: 11287760
[TBL] [Abstract][Full Text] [Related]
4. Association of methylenetetrahydrofolate reductase gene polymorphism with carotid atherosclerosis depending on smoking status in a Japanese general population.
Inamoto N; Katsuya T; Kokubo Y; Mannami T; Asai T; Baba S; Ogata J; Tomoike H; Ogihara T
Stroke; 2003 Jul; 34(7):1628-33. PubMed ID: 12775885
[TBL] [Abstract][Full Text] [Related]
5. [The role of hyperhomocysteinemia on atherosclerosis in patients with chronic renal failure].
Yu Y; Hou F; Zhou H; Yang Y; Zhang X; Yang L; Hu M
Zhonghua Nei Ke Za Zhi; 2002 Aug; 41(8):517-21. PubMed ID: 12421497
[TBL] [Abstract][Full Text] [Related]
6. Hyperhomocysteinemia is related to residual glomerular filtration and folate, but not to methylenetetrahydrofolate-reductase and methionine synthase polymorphisms, in supplemented end-stage renal disease patients undergoing hemodialysis.
Anwar W; Guéant JL; Abdelmouttaleb I; Adjalla C; Gérard P; Lemoel G; Erraess N; Moutabarrek A; Namour F
Clin Chem Lab Med; 2001 Aug; 39(8):747-52. PubMed ID: 11592445
[TBL] [Abstract][Full Text] [Related]
7. An MTHFR variant, homocysteine, and cardiovascular comorbidity in renal disease.
Wrone EM; Zehnder JL; Hornberger JM; McCann LM; Coplon NS; Fortmann SP
Kidney Int; 2001 Sep; 60(3):1106-13. PubMed ID: 11532106
[TBL] [Abstract][Full Text] [Related]
8. Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease.
Hyndman ME; Manns BJ; Snyder FF; Bridge PJ; Scott-Douglas NW; Fung E; Parsons HG
Metabolism; 2003 Feb; 52(2):168-72. PubMed ID: 12601627
[TBL] [Abstract][Full Text] [Related]
9. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
D'Angelo A; Coppola A; Madonna P; Fermo I; Pagano A; Mazzola G; Galli L; Cerbone AM
Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318
[TBL] [Abstract][Full Text] [Related]
10. [Hyperhomocysteinemia, oxidative stress and microinflammation in chronic renal failure: their roles in atherogene].
Yu YM; Hou FF; Zhang X; Zhou H; Liu ZQ
Zhonghua Nei Ke Za Zhi; 2004 Apr; 43(4):292-5. PubMed ID: 15130417
[TBL] [Abstract][Full Text] [Related]
11. Lack of association between carotid intima-media thickness and methylenetetrahydrofolate reductase gene polymorphism or serum homocysteine in non-insulin-dependent diabetes mellitus.
Mazza A; Motti C; Nulli A; Marra G; Gnasso A; Pastore A; Federici G; Cortese C
Metabolism; 2000 Jun; 49(6):718-23. PubMed ID: 10877195
[TBL] [Abstract][Full Text] [Related]
12. Homocysteine and carotid atherosclerosis in chronic renal failure--the confounding effect of renal function.
Leskinen Y; Lehtimäki T; Loimaala A; Huhtala H; Salenius JP; Oja SS; Saha H
Atherosclerosis; 2004 Aug; 175(2):315-23. PubMed ID: 15262188
[TBL] [Abstract][Full Text] [Related]
13. Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.
Tremblay R; Bonnardeaux A; Geadah D; Busque L; Lebrun M; Ouimet D; Leblanc M
Kidney Int; 2000 Aug; 58(2):851-8. PubMed ID: 10916110
[TBL] [Abstract][Full Text] [Related]
14. Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus.
Suliman ME; Stenvinkel P; Bárány P; Heimbürger O; Anderstam B; Lindholm B
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S89-95. PubMed ID: 12612961
[TBL] [Abstract][Full Text] [Related]
15. Plasma homocysteine, methylenetetrahydrofolate reductase gene polymorphism and carotid intima-media thickness in Italian type 2 diabetic patients.
Scaglione L; Gambino R; Rolfo E; Lillaz E; Gai M; Cassader M; Pagano G; Cavallo-Perin P
Eur J Clin Invest; 2002 Jan; 32(1):24-8. PubMed ID: 11851723
[TBL] [Abstract][Full Text] [Related]
16. Correlations between plasma homocysteine and folate concentrations and carotid atherosclerosis in high-risk individuals: baseline data from the Homocysteine and Atherosclerosis Reduction Trial (HART).
Held C; Sumner G; Sheridan P; McQueen M; Smith S; Dagenais G; Yusuf S; Lonn E
Vasc Med; 2008 Nov; 13(4):245-53. PubMed ID: 18940900
[TBL] [Abstract][Full Text] [Related]
17. An association of 5,10-methylenetetrahydrofolate reductase (MTHFR) gene polymorphism and common carotid atherosclerosis.
Kawamoto R; Kohara K; Tabara Y; Miki T; Doi T; Tokunaga H; Konishi I
J Hum Genet; 2001; 46(9):506-10. PubMed ID: 11558898
[TBL] [Abstract][Full Text] [Related]
18. [Methylenetetrahydrofolate reductase gene polymorphism and plasma homocysteine levels in hemodialysing patients].
Yao Y; Liu H; Zhang X; Duan X
Zhonghua Nei Ke Za Zhi; 2002 Aug; 41(8):522-5. PubMed ID: 12421498
[TBL] [Abstract][Full Text] [Related]
19. Association between hyperhomocysteinemia and ultrasonographic atherosclerotic indices of carotid arteries in chronic hemodialysis patients.
Grekas D; Economou H; Makedou A; Destanis E; Theodoridou A; Avdelidou A; Demitriadis A; Tourkantonis A
Nephron Clin Pract; 2005; 101(4):c180-6. PubMed ID: 16103723
[TBL] [Abstract][Full Text] [Related]
20. The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.
Kadziela J; Janas J; Dzielińska Z; Szperl M; Gaździk D; Chotkowska E; Piotrowski W; Ruzyłło W
Kardiol Pol; 2003 Jul; 59(7):17-26; discussion 26. PubMed ID: 14560345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
